Formulation

BB Moisturizing
Cushion Foundation After-Sun Moments

BB foundation cream impregnated into a cushion sponge. Water in silicone emulsion, Ref. SB2016-MFD_6
technology based on complex elastomeric silicone gels. This fluid foundation
refreshes, soothes and moisturizes your skin after sun exposure, while hiding
imperfections and providing a fresh natural even tone.

Take the puff and press it on the cushion sponge to pick up the cream foundation.
Apply the puff on the face to evenly cover the skin surface. Repeat until you get the
desired coverage.

Phase Material Name INCI %

Caresil CSV-30001 Cyclopentasiloxane 15,00

A Cyclopentasiloxane (and) Dimethicone / Vinyl Dimethicone 2,00

Caresil CXG-11011
Crosspolymer

Caresil CSF-3100 5 cst1 Dimethicone 6,00

B KF-60382 Lauryl PEG-9 Polydimethyl Siloxyethyl Dimethicone 3,00

Uvinul MC 80 3
Ethylhexyl Methoxycinnamate 2,50

C Lunacare BGCC4 Butylene Glycol Dicaprylate/ Dicaprate 3,00

DUB DNPG 5
Neopentyl Glycol Diheptanoate 3,00

G-Gel 102V6 Cyclopentasiloxane (and) Ethylhexyl 5,00

Palmitate (and) Quaternium-90
Bentonite (and) Propylene Carbonate

KSP-3002 Diphenyl Dimethicone/Vinyl Diphenyl 2,00

Dimethicone/Silsesquioxane Crosspolymer

TNP40VTTS (32% TiO2)7 C12-15 Alkyl Benzoate (and) Titanium 10,00

D Dioxide (and) Alumina (and)
Polyhydroxystearic Acid (and) Isopropyl Titanium
Triisostearate (and) Triethoxycaprylylsilane

Sheer Beauty8 Fragrance 0,35

Bisabolol RAC3 Bisabolol 0,10

Paratexin PE 9
Phenoxyethanol 0,80

OTS-2 TiO2 CR-50 ( 93%)10 Titanium Dioxide, Aluminum Hydroxide, Hydrated Silica, 9,00
Triethoxycaprylylsilane
E
OTS-2 YELLOW LL-100P10 Iron Oxides, Triethoxycaprylylsilane 0,30

OTS-2 RED R-516P10 Iron Oxides, Triethoxycaprylylsilane 1,00

Suppliers
1
NuSil Technology, 2 Shin Etsu, 3 BASF, 4 DKSH, 5 Stearinerie Dubois, 6 Applechem, 7 Kobo, 8 IFF, 9 Azelis,
10
Daito Kasei
Genencare® OSMS BA/MI
After Sun Moments | BB Moisturizing Cushion Foundation
Ref. SB2016-MFD_6

Phase Material Name INCI %

OTS-2 BLACK BL-100P10 Iron Oxides, Triethoxycaprylylsilane 0,20

E
BPD-500w 7
HDI/Trimethylol Hexyllactone Crosspolymer (and) Silica 3,00

Demin Water Aqua 19,25

GENENCARE OSMS BA
® 11
Betaine 4,00

GENENCARE® OSMS MI11 Inositol 1,00

F
Makilene CG 10
1,3 Butanediol 3,50

NaCl Sodium Chloride 1,00

Ethanol Alcohol denat 5,00

Suppliers
7
Kobo, 10 Daito Kasei, 11 DuPont

Procedure Characteristics
1. Disperse well the ingredients of phase A and mix until Aspect Fluid emulsion
uniform and without any lumps. Color Beige nude
2. Add the ingredient of phase B into phase A and keep stirring Odor Perfumed
until homogeneous. pH 5,5 – 5,7
3. Add the ingredients of phase C into the blend AB and keep Viscosity 1500 cps (RV5/30 rpm)
stirring until homogeneous. Stability 1 month RT/40°C stable
4. Add the ingredients of phase D into the blend ABC and keep
stirring with a high shear mixer until uniform and without
any lumps.
5. Add the ingredients of phase E after grinding into the blend
ABCD and mix with a high shear mixer until uniform and
without any pigment agglomeration.
6. Combine the ingredients of phase F and mix until dissolved.
7. Add very slowly phase F into the blend ABCDE while
stirring.
8. Homogenize a few minutes for viscosity build-up and water
droplet size repartition.

Formulation developed by MFD Consult.

Made in Belgium.

Industrial Biosciences
biosciences.dupont.com/
personalcare
Copyright © 2019 DuPont or its affiliates. All rights reserved. The DuPont logo, DuPont™ and GENENCARE® are trademarks of DuPont (DowDuPont Inc.) or its affiliates.
The sample formulations set forth herein are intended for use by persons having appropriate technical and formulation expertise and DuPont assumes no liability for use
of these formulations. DuPont provides these sample formulations to inspire customer specific formulations that may contain GENENCARE® OSMS BA,
GENENCARE® OSMS MI and these formulations are not intended for final use, nor have they been assessed for performance, efficacy, suitability, stability or safety, this
remains the sole responsibility of receiver. Conditions and methods of use of DuPont’s products are beyond our control, and nothing contained herein shall be construed
as a representation or warranty on use or of non-infringement of intellectual property, regulatory or legal compliance. DuPont has only assessed its product in isolation
and the law requires that its concentration is appropriate for the final efficacy claims and that any interaction with other ingredients would require further evaluation. If this
document/presentation is provided in any language other than English, the original English version will control, and DuPont hereby disclaims responsibility for any errors
caused by translation.

03.19.V1